December 10th, 2016
•This protocol outlines the cefoperazone mouse model of Clostridium difficile infection (CDI) using a clinically-relevant and genetically-tractable strain, R20291. Emphasis on clinical disease monitoring, C. difficile bacterial enumeration, toxin cytotoxicity, and histopathological changes throughout CDI in a mouse model are detailed in the protocol.
Related Videos
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Influenza A Virus Studies in a Mouse Model of Infection
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
A Purification and In Vitro Activity Assay for a (p)ppGpp Synthetase from Clostridium difficile
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Copyright © 2024 MyJoVE Corporation. 판권 소유